2025-08-10 Drugs SFDA Launches an Initiative to Enable Healthcare Professionals and Patients to Access Awareness Materials that Promote the Safe Use of Medications and Help Minimize Related Risks
2025-07-29 Drugs SFDA Approves the Registration of “Leqembi” as the First Alzheimer’s Treatment in Saudi Arabia
2025-07-23 Drugs SFDA Announces Registration of “Skyclarys” for the Treatment of a Rare Genetic Neurological Disorder
2025-07-16 Drugs SFDA Approves Marketing Authorization for Diagnostic Medical Devices to Measure Antipsychotic Drug Levels in Blood
2025-07-14 Drugs SFDA Suspends European Pharmaceutical Factory Due to Critical Manufacturing Violations
2025-07-10 Drugs The SFDA Approves the Registration of “Winrevair” for the Treatment of Pulmonary Arterial Hypertension under the Orphan Drug Designation Pathway
2025-05-31 Food, Drugs, Medical Devices The SFDA Hajj Operations Center Offers Immediate Response to Reports and Maintains Coordination with Government Entities
